Towards a Universal Molecular Microbiological Test

ABSTRACT The standard paradigm for microbiological testing is dependent on the presentation of a patient to a clinician. Tests are then requested based on differential diagnoses using the patient's symptoms as a guide. The era of high-throughput genomic methods has the potential to replace this model for the first time with what could be referred to as “hypothesis-free testing.” This approach utilizes one of a variety of methodologies to obtain a sequence from potentially any nucleic acid in a clinical sample, without prior knowledge of its content. We discuss the advantages of such an approach and the challenges in making this a reality.

[1]  M. Aepfelbacher,et al.  Evaluation of Unbiased Next-Generation Sequencing of RNA (RNA-seq) as a Diagnostic Method in Influenza Virus-Positive Respiratory Samples , 2015, Journal of Clinical Microbiology.

[2]  Chao Xie,et al.  Fast and sensitive protein alignment using DIAMOND , 2014, Nature Methods.

[3]  Zhen Lin,et al.  Microbial Contamination in Next Generation Sequencing: Implications for Sequence-Based Analysis of Clinical Samples , 2014, PLoS pathogens.

[4]  Xiaochen Bo,et al.  Direct next-generation sequencing of virus-human mixed samples without pretreatment is favorable to recover virus genome , 2016, Biology Direct.

[5]  D. Relman,et al.  Sequence-based identification of microbial pathogens: a reconsideration of Koch's postulates , 1996, Clinical microbiology reviews.

[6]  Alexander S. Mikheyev,et al.  A first look at the Oxford Nanopore MinION sequencer , 2014, Molecular ecology resources.

[7]  Richard M Leggett,et al.  MinION Analysis and Reference Consortium: Phase 2 data release and analysis of R9.0 chemistry , 2017, F1000Research.

[8]  S. Brisse,et al.  Evaluation of High-Throughput Sequencing for Identifying Known and Unknown Viruses in Biological Samples , 2011, Journal of Clinical Microbiology.

[9]  Martin C. Frith,et al.  MinION Analysis and Reference Consortium: Phase 2 data release and analysis of R9.0 chemistry , 2017, F1000Research.

[10]  A. Clarke Managing the ethical challenges of next-generation sequencing in genomic medicine. , 2014, British medical bulletin.

[11]  S. Davey Next generation sequencing: considering the ethics , 2014, International journal of immunogenetics.

[12]  I. Rudan,et al.  The role of host genetic factors in respiratory tract infectious diseases: systematic review, meta-analyses and field synopsis , 2015, Scientific Reports.

[13]  David A. Matthews,et al.  Real-time, portable genome sequencing for Ebola surveillance , 2016, Nature.

[14]  Lisa C. Crossman,et al.  Identification of bacterial pathogens and antimicrobial resistance directly from clinical urines by nanopore-based metagenomic sequencing , 2016, The Journal of antimicrobial chemotherapy.

[15]  Sharon J. Peacock,et al.  Whole-genome sequencing to control antimicrobial resistance , 2014, Trends in genetics : TIG.

[16]  Trevor Bedford,et al.  Multiplex PCR method for MinION and Illumina sequencing of Zika and other virus genomes directly from clinical samples , 2017, Nature Protocols.

[17]  K. Eilbeck,et al.  Unbiased Detection of Respiratory Viruses by Use of RNA Sequencing-Based Metagenomics: a Systematic Comparison to a Commercial PCR Panel , 2016, Journal of Clinical Microbiology.

[18]  L. Ross,et al.  Reporting Incidental Findings in Genomic Scale Clinical Sequencing-A Clinical Laboratory Perspective: A Report of the Association for Molecular Pathology. , 2015, The Journal of molecular diagnostics : JMD.

[19]  S. Domchek,et al.  Multiplex genetic testing: reconsidering utility and informed consent in the era of next-generation sequencing , 2014, Genetics in Medicine.

[20]  Y. Guan,et al.  Antiviral resistance among highly pathogenic influenza A (H5N1) viruses isolated worldwide in 2002-2012 shows need for continued monitoring. , 2013, Antiviral research.

[21]  Gabrielle M. Christenhusz,et al.  Towards a European consensus for reporting incidental findings during clinical NGS testing , 2015, European Journal of Human Genetics.

[22]  Chunlei Du,et al.  Nanopore-based Fourth-generation DNA Sequencing Technology , 2015, Genom. Proteom. Bioinform..

[23]  Bas E. Dutilh,et al.  Beyond research: a primer for considerations on using viral metagenomics in the field and clinic , 2015, Front. Microbiol..

[24]  E. Delwart,et al.  Comparing viral metagenomics methods using a highly multiplexed human viral pathogens reagent , 2014, Journal of Virological Methods.

[25]  Joseph L DeRisi,et al.  Actionable diagnosis of neuroleptospirosis by next-generation sequencing. , 2014, The New England journal of medicine.

[26]  R M A Graham,et al.  Epidemiological typing of Neisseria gonorrhoeae and detection of markers associated with antimicrobial resistance directly from urine samples using next generation sequencing , 2016, Sexually Transmitted Infections.

[27]  Doug Stryke,et al.  Rapid metagenomic identification of viral pathogens in clinical samples by real-time nanopore sequencing analysis , 2015, Genome Medicine.

[28]  P. Hugenholtz,et al.  Multiple displacement amplification compromises quantitative analysis of metagenomes , 2010, Nature Methods.

[29]  M. Beer,et al.  The Origin of Biased Sequence Depth in Sequence-Independent Nucleic Acid Amplification and Optimization for Efficient Massive Parallel Sequencing , 2013, PloS one.

[30]  Phelim Bradley,et al.  Same-Day Diagnostic and Surveillance Data for Tuberculosis via Whole-Genome Sequencing of Direct Respiratory Samples , 2016, Journal of Clinical Microbiology.

[31]  Richard W. Lusk Diverse and Widespread Contamination Evident in the Unmapped Depths of High Throughput Sequencing Data , 2014, bioRxiv.

[32]  Michael Bunce,et al.  From Benchtop to Desktop: Important Considerations when Designing Amplicon Sequencing Workflows , 2015, PloS one.

[33]  Yue Wang,et al.  The evolution of nanopore sequencing , 2014, Front. Genet..

[34]  B. Lopman,et al.  Host Genetic Susceptibility to Enteric Viruses: A Systematic Review and Metaanalysis. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[35]  B. Knoppers,et al.  To disclose, or not to disclose? Context matters , 2014, European Journal of Human Genetics.

[36]  Christoph Endrullat,et al.  Standardization and quality management in next-generation sequencing , 2016, Applied & translational genomics.

[37]  Robert Schlaberg,et al.  Validation of Metagenomic Next-Generation Sequencing Tests for Universal Pathogen Detection. , 2017, Archives of pathology & laboratory medicine.

[38]  Kyoung-Ho Kim,et al.  Amplification Methods Bias Metagenomic Libraries of Uncultured Single-Stranded and Double-Stranded DNA Viruses , 2011, Applied and Environmental Microbiology.